These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19721252)

  • 1. Synthesis and biological activity of enantiomeric pairs of 5-(Alk-2-enyl)thiolactomycin and 5-[(E)-Cycloalk-2-enylidenemethyl]thiolactomycin congeners.
    Ohata K; Terashima S
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):920-36. PubMed ID: 19721252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of enantiomeric pairs of 5-vinylthiolactomycin congeners.
    Ohata K; Terashima S
    Bioorg Med Chem Lett; 2007 Jul; 17(14):4070-4. PubMed ID: 17507223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of enantiomeric pairs of 5-[(E)-cycloalk-2-enylidenemethyl]thiolactomycin congeners.
    Ohata K; Terashima S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5598-600. PubMed ID: 18805004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.
    Slayden RA; Lee RE; Armour JW; Cooper AM; Orme IM; Brennan PJ; Besra GS
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2813-9. PubMed ID: 9124847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of thiotetronic acid analogues of thiolactomycin.
    Sakya SM; Suarez-Contreras M; Dirlam JP; O'Connell TN; Hayashi SF; Santoro SL; Kamicker BJ; George DM; Ziegler CB
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2751-4. PubMed ID: 11591516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity.
    Douglas JD; Senior SJ; Morehouse C; Phetsukiri B; Campbell IB; Besra GS; Minnikin DE
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3101-3109. PubMed ID: 12368443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.
    McFadden JM; Medghalchi SM; Thupari JN; Pinn ML; Vadlamudi A; Miller KI; Kuhajda FP; Townsend CA
    J Med Chem; 2005 Feb; 48(4):946-61. PubMed ID: 15715465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type selective inhibition of microbial fatty acid synthases by thiolactomycin.
    Arimura N; Kaneda T
    Arch Microbiol; 1993; 160(2):158-61. PubMed ID: 8379811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
    Bommineni GR; Kapilashrami K; Cummings JE; Lu Y; Knudson SE; Gu C; Walker SG; Slayden RA; Tonge PJ
    J Med Chem; 2016 Jun; 59(11):5377-90. PubMed ID: 27187871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli.
    Hayashi T; Yamamoto O; Sasaki H; Kawaguchi A; Okazaki H
    Biochem Biophys Res Commun; 1983 Sep; 115(3):1108-13. PubMed ID: 6354189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2004 Jan; 14(2):373-6. PubMed ID: 14698162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli.
    Nishida I; Kawaguchi A; Yamada M
    J Biochem; 1986 May; 99(5):1447-54. PubMed ID: 3519604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flexible route to (5R)-thiolactomycin, a naturally occurring inhibitor of fatty acid synthesis.
    McFadden JM; Frehywot GL; Townsend CA
    Org Lett; 2002 Oct; 4(22):3859-62. PubMed ID: 12599477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthetic origins of the natural product, thiolactomycin: a unique and selective inhibitor of type II dissociated fatty acid synthases.
    Brown MS; Akopiants K; Resceck DM; McArthur HA; McCormick E; Reynolds KA
    J Am Chem Soc; 2003 Aug; 125(34):10166-7. PubMed ID: 12926927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural fatty acid synthase inhibitors as potent therapeutic agents for cancers: A review.
    Zhang JS; Lei JP; Wei GQ; Chen H; Ma CY; Jiang HZ
    Pharm Biol; 2016 Sep; 54(9):1919-25. PubMed ID: 26864638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12.
    Tsay JT; Rock CO; Jackowski S
    J Bacteriol; 1992 Jan; 174(2):508-13. PubMed ID: 1729241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fatty acid synthesis by the antibiotic thiolactomycin.
    Hayashi T; Yamamoto O; Sasaki H; Okazaki H; Kawaguchi A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1456-61. PubMed ID: 6511668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents.
    Jones SM; Urch JE; Brun R; Harwood JL; Berry C; Gilbert IH
    Bioorg Med Chem; 2004 Feb; 12(4):683-92. PubMed ID: 14759729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of thiolactomycin on fatty acid biosynthesis in Streptomyces collinus.
    Wallace KK; Lobo S; Han L; McArthur HA; Reynolds KA
    J Bacteriol; 1997 Jun; 179(12):3884-91. PubMed ID: 9190803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB.
    Furukawa H; Tsay JT; Jackowski S; Takamura Y; Rock CO
    J Bacteriol; 1993 Jun; 175(12):3723-9. PubMed ID: 8509326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.